Stay updated on Epacadostat & Pembrolizumab in GIST Clinical Trial
Sign up to get notified when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.

Latest updates to the Epacadostat & Pembrolizumab in GIST Clinical Trial page
- ChecktodayChange DetectedThe site revision label in the footer changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check7 days agoChange DetectedThe site revision label in the footer changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check28 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden error. The full study details are no longer visible, replaced by an error page.SummaryDifference19%

- Check49 days agoChange DetectedThe page shows a new revision tag, updating from v3.6.5 to v3.6.6, indicating a minor site version update with no visible changes to content or study information.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, reflecting a new deployment of the page template. This update indicates a minor backend or UI framework revision without changing study content or participant-facing information.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page shows a new Revision: v3.6.4 replacing v3.6.3, indicating a small update to the page version. No substantive study details appear to be changed.SummaryDifference0.1%

Stay in the know with updates to Epacadostat & Pembrolizumab in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.